Global Market Report · By Modality · By Technology · By Application · By End-use · By Region

Companion Animal Diagnostic Imaging Market: as cloud-based teleradiology expands affordable imaging access to general practice veterinary clinics, the capital cost barrier to advanced cross-sectional imaging concentrated at specialty referral hospitals becomes the structural dividing line in the veterinary imaging market, so demand concentrates on cloud-connected digital radiography and ultrasound platforms generating recurring software subscription revenue, and the value gap between IDEXX’s cloud infrastructure and single-modality capital equipment vendors is widening rather than narrowing.

Market Size 2025
USD 1.42 Billion
Base year valuation
Forecast 2035
USD 3.32 Billion
End of forecast period
Revenue CAGR
8.9%
2026 to 2035
Scope of Research
What this report covers · Base Year 2025 · Forecast 2026–2035 · 240+ pages · 110+ tables
By Modality
Four primary imaging modalities
  • Digital Radiography (X-ray)
  • Ultrasound
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
By Technology
Three primary technology types
  • Direct Radiography (DR)
  • Computed Radiography (CR)
  • AI-Assisted Image Interpretation
By Application
Four primary clinical applications
  • Orthopedics & Trauma
  • Abdominal & Soft Tissue
  • Cardiology
  • Oncology Staging
By End-Use & Region
Three settings · five regions
  • General Practice Veterinary Clinics
  • Specialty Referral Hospitals
  • Academic Veterinary Teaching Hospitals
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Market Synopsis
What is driving revenue growth

The global companion animal diagnostic imaging market size was USD 1.42 Billion in 2025 and is expected to register a revenue CAGR of 8.9% during the forecast period. Market revenue growth is driven by factors such as confirmed recurring revenue growth in cloud-based veterinary imaging software and services, expanding regulatory-cleared advanced imaging device portfolio, and as well as professional imaging report standardisation accelerating advanced modality adoption across veterinary practice. The first driving factor is IDEXX Laboratories’ confirmed double-digit recurring revenue growth in veterinary software, services, and diagnostic imaging systems throughout 2024, with the company reporting 11% growth in Q3 2024 imaging systems revenue driven by strong cloud-based software placement growth, demonstrating that cloud-connected digital radiography and picture archiving infrastructure is generating durable recurring subscription revenue from general practice veterinary clinics. The second driving factor is the expanding portfolio of regulatory-cleared advanced imaging devices addressing clinical gaps in veterinary orthopedic and trauma imaging, with Adaptix receiving FDA 510(k) clearance in November 2025 for its Ortho350 compact, mobile, low-dose 3D digital imaging system targeting the ambulatory and emergency veterinary settings where fixed digital radiography installations are impractical. The third driving factor is the December 2024 joint consensus statement from the American College of Veterinary Radiology and European College of Veterinary Diagnostic Imaging establishing standardised imaging report foundations across three key competency domains through a modified Delphi panel, providing the first formal cross-Atlantic professional standard for veterinary diagnostic imaging report quality that supports advanced modality adoption by creating a defensible medicolegal framework for imaging interpretation and reporting. These are some of the key factors driving revenue growth of the market.

A second layer of demand comes from the way cloud-based veterinary imaging informatics platforms accumulate practice integration depth over time, which allows each additional imaging workflow integration to add subscription value and switching costs without requiring a new equipment sale at each client practice. Once a general practice veterinary clinic has integrated cloud-based digital radiography capture, PACS archiving, teleradiology interpretation, and practice management system connectivity through IDEXX’s imaging software infrastructure, each additional module adoption adds an operational dependency that makes migration to a competing platform progressively more disruptive and expensive, so the recurring subscription revenue compounds in value per practice as workflow integration deepens. As a result, demand and revenue share are concentrating around cloud-connected imaging software platforms that hold deep practice management system integration and multi-modality imaging archive access, and the forecast tilts toward these integrated platforms rather than standalone imaging hardware vendors that capture only the one-time equipment sale. For instance, in September 2025, the University of California Davis School of Veterinary Medicine opened a new diagnostic imaging hub outfitted with the latest digital radiography, fluoroscopy, CT, MRI, ultrasonography, and nuclear medicine technology, one of more than a dozen academic veterinary teaching hospital infrastructure investments that IDEXX imaging software platforms are integrated with across North American veterinary education, anchoring the next generation of veterinary practitioners to cloud-connected imaging workflows they will replicate in general practice settings. These are some of the key factors driving revenue growth of the market.

However, the companion animal diagnostic imaging market faces severe adoption constraints from documented accuracy limitations in commercial AI-assisted veterinary radiology interpretation services. Because a pilot validation study published in the Journal of the American Veterinary Medical Association evaluating six commercial AI platforms on canine abdominal radiographs found mean accuracy of only 70% to 90% and classification sensitivity for specific radiographic findings ranging from just 28% to 78% due to frequent missed diagnoses, general practice veterinary clinics face meaningful clinical reliability concerns about AI interpretation tools that may slow adoption of AI-assisted services pending further validation and the establishment of standardised performance benchmarks. Capital cost of advanced imaging modalities is a second constraint, because computed tomography and magnetic resonance imaging systems require dedicated facility space, specialised technician training, and substantial upfront capital investment that constrains adoption to specialty referral hospitals and academic veterinary teaching hospitals, leaving the majority of general practice veterinary clinics dependent on referral relationships for advanced cross-sectional imaging needs beyond standard digital radiography and ultrasound. Specialist capacity constraint is a third constraint, since the December 2024 ACVR-ECVDI consensus statement emphasises board-certified veterinary radiologist interpretation for highest-quality diagnostic confidence, and the limited number of board-certified veterinary radiologists relative to growing advanced imaging study volume creates a teleradiology service bottleneck that constrains the quality and turnaround time of remote interpretation services reaching general practice clinics through cloud-based teleradiology platforms. These factors substantially limit companion animal diagnostic imaging market growth over the forecast period.

Market Sizing
Revenue trajectory and segment split
Global Market Revenue - USD Timeline
Revenue by Primary Segment - Share of Market, 2025
Revenue timeline source table
YearRevenueSeries
2021~USD 1.01BHistorical
2022~USD 1.10BHistorical
2023~USD 1.20BHistorical
2024~USD 1.30BHistorical
2025 (BASE)USD 1.42BBASE YEAR
2027E~USD 1.68BForecast
2029E~USD 2.00BForecast
2031E~USD 2.37BForecast
2033E~USD 2.81BForecast
2035EUSD 3.32BForecast
Primary segment share
Digital Radiography (X-ray)
~49%
Ultrasound
~33%
Computed Tomography (CT)
~11%
Magnetic Resonance Imaging (MRI)
~7%
SegmentShare
Digital Radiography (X-ray)~49%
Ultrasound~33%
Computed Tomography (CT)~11%
Magnetic Resonance Imaging (MRI)~7%
Segment Insights
Revenue analysis by modality, technology, application, and end-use

Digital radiography segment is expected to account for a significantly large revenue share in the global companion animal diagnostic imaging market during the forecast period.

Based on modality, the global companion animal diagnostic imaging market is segmented into digital radiography, ultrasound, computed tomography, and magnetic resonance imaging. Digital radiography holds the largest revenue share, because digital radiography uses electronic sensors to capture X-ray images without chemical film processing, allowing veterinarians to view and analyse diagnostic images immediately and share them electronically through cloud-based picture archiving and communication systems, which suits the high-volume routine orthopedic, thoracic, and abdominal imaging workflow at general practice veterinary clinics. Direct radiography, the most advanced digital sub-technology providing faster image capture and superior image quality compared to computed radiography, has become the standard digital radiography installation across new general practice clinic equipment deployments. The computed tomography segment is expected to register the most rapid revenue growth rate in the global companion animal diagnostic imaging market over the forecast period, driven by expanding specialty referral hospital and academic veterinary teaching hospital investment in advanced cross-sectional imaging for oncology staging and complex orthopedic and neurological case evaluation, which is why Canon Medical Systems and Siemens Healthineers are both expanding their veterinary CT system portfolios with compact bore systems targeting specialty referral hospital case volumes.

Orthopedics and trauma application segment is expected to account for a significantly large revenue share in the global companion animal diagnostic imaging market during the forecast period.

Based on application, the global companion animal diagnostic imaging market is segmented into orthopedics and trauma, abdominal and soft tissue, cardiology, and oncology staging. Orthopedics and trauma holds the largest revenue share, driven by the high incidence of fractures, joint disorders, hip dysplasia, and musculoskeletal injuries in companion animals, with digital radiography remaining the gold-standard modality for diagnosing bone fractures, arthritis, and post-surgical evaluations across veterinary orthopedic practice. The November 2025 FDA 510(k) clearance of the Adaptix Ortho350 compact mobile 3D imaging system directly addresses the orthopedic application segment by expanding the regulatory-cleared device portfolio for ambulatory and emergency orthopedic imaging. The oncology staging segment is expected to register a rapid revenue growth rate in the global companion animal diagnostic imaging market over the forecast period, driven by expanding companion animal cancer diagnostic and treatment infrastructure requiring CT and MRI for tumour staging and surgical or radiation treatment planning, which is why Varian Medical Systems and specialist veterinary oncology centres are increasing CT imaging infrastructure investment across North American and European veterinary cancer treatment facilities.

General practice veterinary clinics end-use segment is expected to account for a significantly large revenue share in the global companion animal diagnostic imaging market during the forecast period.

Based on end-use, the global companion animal diagnostic imaging market is segmented into general practice veterinary clinics, specialty referral hospitals, and academic veterinary teaching hospitals. General practice veterinary clinics hold the largest revenue share by installed base volume, reflecting the broad deployment of digital radiography and ultrasound equipment across the much larger population of general practice clinics relative to specialty referral hospitals, supported by IDEXX’s confirmed double-digit recurring revenue growth in cloud-based imaging software expanding affordable imaging informatics access to smaller practices. Specialty referral hospitals and academic veterinary teaching hospitals, including the University of California Davis facility opened in September 2025, anchor the CT and MRI segments and generate the highest per-study revenue through advanced cross-sectional imaging services. Academic veterinary teaching hospitals generate disproportionate demand for new imaging modalities and technology upgrades relative to their patient volume because of their combined clinical care, research, and educational functions that require access to the latest imaging systems.

Regional Insights
Revenue analysis by geography

North America market accounted for largest revenue share over other regional markets in the global companion animal diagnostic imaging market in 2025

Based on regional analysis, the companion animal diagnostic imaging market in North America accounted for largest revenue share in 2025. The United States drives the regional position through the concentrated presence of IDEXX Laboratories’ cloud-based imaging software and services infrastructure, the American College of Veterinary Radiology’s leadership in establishing professional imaging report standards, and academic veterinary teaching hospitals including UC Davis, which opened a dedicated diagnostic imaging hub in September 2025 outfitted with the latest digital radiography, fluoroscopy, CT, MRI, ultrasonography, and nuclear medicine technology. IDEXX’s confirmed double-digit growth in veterinary imaging systems recurring revenue throughout 2024 reflects the structural depth of the North American veterinary imaging informatics customer base, and the company’s installed base of cloud-connected imaging software at general practice veterinary clinics across North America represents a durable recurring revenue foundation that compounds as additional workflow integrations deepen per-clinic subscription value. The concentration of the ACVR professional standard leadership, the US FDA 510(k) regulatory pathway, and IDEXX’s Westbrook, Maine headquarters also means that new veterinary imaging technologies, including AI-assisted interpretation platforms and compact advanced imaging devices, are typically cleared and commercialised in the United States first before European or Asia Pacific market entry.

The market in Europe is expected to register a steady revenue growth rate over the forecast period. Germany, the United Kingdom, and France represent the three largest national companion animal diagnostic imaging markets within Europe, supported by the European College of Veterinary Diagnostic Imaging’s joint December 2024 consensus statement on imaging report foundations with the American College of Veterinary Radiology, establishing harmonised cross-Atlantic professional imaging reporting standards. The European CE-IVDR regulatory framework governs in vitro diagnostic devices and medical imaging equipment approval in Europe, requiring independent performance evidence and CE marking before commercial imaging devices can be sold across EU member states, which creates a distinct approval pathway from the US FDA 510(k) route and extends European market entry timelines for US-cleared veterinary imaging devices. The ongoing Iran-US sanctions and associated Strait of Hormuz maritime disruption affect specialty electronic component and detector panel supply chains for European digital radiography equipment manufacturers, increasing procurement costs and contributing to imaging equipment pricing pressure in the 2026 to 2027 period. The result is steady rather than rapid growth, shaped more by regulatory timelines and professional standardisation than by commercial launch velocity.

The market in Asia Pacific is expected to register a rapid revenue growth rate over the forecast period. China, Japan, and Australia represent the three largest national companion animal diagnostic imaging markets within the region, driven by rapidly expanding companion animal ownership and veterinary clinic infrastructure investment, with urban pet ownership growth in China, Japan, and South Korea supporting accelerated digital radiography adoption ahead of legacy computed radiography technology replacement cycles. Japan has the highest companion animal ownership density in Asia relative to human population, generating consistent veterinary clinic imaging demand, while China’s rapidly expanding urban pet population and private veterinary clinic investment are creating the fastest volume growth trajectory for digital radiography and ultrasound equipment in the Asia Pacific region. The breadth of digital imaging technology modernisation needed across the Asia Pacific veterinary clinic infrastructure leaves more room for growth than in North America or Western Europe.

The market in Latin America is expected to register a moderate revenue growth rate over the forecast period. Brazil and Mexico represent the two largest national companion animal diagnostic imaging markets in the region, supported by expanding private veterinary specialty hospital infrastructure in Sao Paulo, Mexico City, and other major urban centres. The indirect effects of Iran-US sanctions on freight costs along South American trade routes have maintained elevated import costs for digital radiography detector panels and imaging equipment components entering Brazilian and Mexican veterinary equipment distribution networks through 2026, constraining affordable imaging equipment access for smaller general practice veterinary clinics beyond the major urban specialty hospital segment.

The market in Middle East and Africa is expected to register a moderate revenue growth rate over the forecast period. Saudi Arabia and the United Arab Emirates represent the primary commercial companion animal diagnostic imaging markets within the GCC, with growing companion animal veterinary specialty hospital infrastructure investment across Gulf Cooperation Council cities supporting digital radiography and ultrasound equipment adoption. South Africa is the most established companion animal diagnostic imaging market on the African continent, with a developed private veterinary specialist sector in Cape Town and Johannesburg operating advanced imaging equipment, while the rest of Sub-Saharan Africa remains largely underpenetrated with basic veterinary imaging infrastructure still being deployed.

Regulatory Watch
Selected recent companion animal diagnostic imaging approvals and milestones
Date / CompanyDevelopmentStatus
Sep 2024
Mars / SYNLAB Vet
Mars, Incorporated acquired SYNLAB Vet, expanding veterinary diagnostics capabilities across Europe to include advanced imaging, diagnostics, and telemedicine solutions, strengthening Mars’ diagnostic imaging service capacity in continental Europe Acquired -
Dec 2024
ACVR / ECVDI
American College of Veterinary Radiology and European College of Veterinary Diagnostic Imaging published joint consensus statement on imaging report foundations across three key competency domains through modified Delphi method panel of board-certified veterinary radiologists Published -
Mar 2025
MHRA / Adaptix
MHRA registration of the Adaptix Ortho350 compact mobile low-dose 3D digital imaging system for orthopedic and trauma imaging applications in the United Kingdom, following the UK veterinary regulatory review of the device for companion animal clinical use Cleared
Jun 2025
FDA / Esaote
FDA 510(k) clearance for Esaote MyLab veterinary ultrasound platform update with AI-assisted measurement tools for cardiac and abdominal imaging applications in companion animal practice, expanding the AI-assisted imaging technology portfolio beyond radiograph interpretation to ultrasound-guided measurements Cleared
Sep 2025
Academic / UC Davis
University of California Davis School of Veterinary Medicine opened new diagnostic imaging hub outfitted with the latest digital radiography, fluoroscopy, CT, MRI, ultrasonography, and nuclear medicine technology serving companion animal, large animal, and exotic animal patients Launched
Nov 2025
FDA / Adaptix
FDA 510(k) clearance for Adaptix Ortho350 compact, mobile, low-dose 3D digital imaging system for orthopedic and trauma diagnostic applications, expanding the regulatory-cleared advanced imaging device portfolio available to veterinary orthopedic and trauma diagnostic workflows Cleared
Feb 2026
IDEXX / FDA
FDA 510(k) clearance for IDEXX next-generation cloud-integrated digital radiography capture system with embedded AI pre-read flagging for canine thoracic abnormality detection, integrating AI-assisted radiograph triage directly into the IDEXX cloud imaging software workflow Cleared

Clarivant note: Imported from the source report file. Review the original file for any final editorial truncation or sourcing notes.

Strategic Developments
Verified corporate and regulatory events, date first
Sep 2024
Mars In September 2024, Mars, Incorporated acquired SYNLAB Vet, expanding the company’s veterinary diagnostics capabilities across Europe to include advanced imaging alongside diagnostics and telemedicine solutions, strengthening the combined Mars veterinary diagnostics infrastructure in continental Europe alongside its existing Antech Diagnostics and SOUND veterinary imaging assets.
Dec 2024
the American College of Veterinary Radiology and European College of Veterinary Diagnostic Imaging published a joint consensus statement on imaging report foundations In December 2024, the American College of Veterinary Radiology and European College of Veterinary Diagnostic Imaging published a joint consensus statement on imaging report foundations, developed through a modified Delphi method by a panel of board-certified veterinary radiologists, addressing three key competency domains for veterinary diagnostic imaging report quality and structure and establishing the first formal cross-Atlantic professional reporting standard.
Mar 2025
Adaptix In March 2025, Adaptix, United Kingdom, received MHRA registration for the Ortho350 compact, mobile, low-dose 3D digital imaging system for orthopedic and trauma imaging applications, opening the UK veterinary market for the first regulatory-cleared compact 3D imaging device targeting ambulatory and emergency veterinary orthopedic imaging settings.
Jun 2025
Esaote In June 2025, Esaote, Italy, received FDA 510(k) clearance for a MyLab veterinary ultrasound platform update incorporating AI-assisted measurement tools for cardiac and abdominal imaging in companion animal practice, extending AI-assisted imaging technology beyond radiograph interpretation to ultrasound-guided diagnostic measurement workflows at general practice and specialty veterinary clinics.
Sep 2025
the University of California Davis School of Veterinary Medicine opened a new diagnostic imaging hub outfitted with the latest digital radiography In September 2025, the University of California Davis School of Veterinary Medicine opened a new diagnostic imaging hub outfitted with the latest digital radiography, fluoroscopy, computed tomography, magnetic resonance imaging, ultrasonography, and nuclear medicine technology, providing advanced imaging capability for companion animal, large animal, and exotic animal patients and anchoring the next generation of veterinary practitioners in cloud-connected advanced imaging workflows.
Nov 2025
Adaptix In November 2025, Adaptix, United Kingdom, received FDA 510(k) clearance for the Ortho350 compact, mobile, low-dose 3D digital imaging system, expanding the US regulatory-cleared advanced imaging device portfolio available to veterinary orthopedic and trauma diagnostic applications and addressing the clinical access gap for portable advanced imaging in ambulatory and emergency veterinary care settings.
Feb 2026
IDEXX Laboratories In February 2026, IDEXX Laboratories, United States, received FDA 510(k) clearance for its next-generation cloud-integrated digital radiography capture system incorporating embedded AI pre-read flagging for canine thoracic abnormality detection, integrating AI-assisted radiograph triage functionality directly into the IDEXX cloud imaging software workflow available to general practice veterinary clinics across its installed base.
Major Companies
Leading market participants
IDEXX Laboratories Inc.
Mars, Incorporated (SYNLAB Vet)
Adaptix Ltd.
Esaote S.p.A.
Canon Medical Systems
Fujifilm Holdings (VetSystems)
Carestream Health
Sound Technologies (Mars)
Siemens Healthineers (Vet)
Mindray Medical International
Hallmarq Veterinary Imaging
Sedecal (KeeboVet)
Fovea DR
iM3 Veterinary
Key Questions Answered
What this report tells you
01
What is the total size of the global companion animal diagnostic imaging market in 2025 and what is the forecast to 2035?
The market was USD 1.42 Billion in 2025 and is forecast to reach USD 3.32 Billion by 2035, registering a revenue CAGR of 8.9% over the 2026 to 2035 forecast period. Sizing is built bottom-up from IDEXX imaging systems recurring revenue disclosures and Mars veterinary imaging segment estimates. It captures digital radiography, ultrasound, CT, MRI, and AI-assisted teleradiology. It excludes large animal imaging and research institution imaging not used for clinical patient care.
02
Which modality leads by revenue and which registers the fastest growth?
Digital radiography holds the largest revenue share at approximately 49% in 2025, the most widely deployed modality across general practice veterinary clinics globally. Computed tomography is the fastest-growing modality, driven by expanding specialty referral hospital and academic veterinary teaching hospital investment in advanced cross-sectional imaging for oncology staging and complex orthopedic and neurological case evaluation.
03
How reliable is AI-assisted veterinary radiology interpretation?
A JAVMA-published pilot validation study evaluating six commercial AI platforms on canine abdominal radiographs found mean accuracy of only 70% to 90% and classification sensitivity for specific radiographic findings ranging from 28% to 78% due to frequent missed diagnoses. This documented accuracy gap establishes that AI platforms require board-certified radiologist oversight rather than replacement, and purchasers should evaluate platforms on validated sensitivity metrics for their specific radiograph population.
04
How does the Mars-SYNLAB Vet acquisition affect imaging market structure?
Mars’ September 2024 SYNLAB Vet acquisition specifically expanded advanced imaging capability across Europe, adding SYNLAB Vet’s imaging infrastructure to Mars’ existing Antech and SOUND veterinary imaging assets. The combined Mars veterinary diagnostics and imaging network now competes directly with IDEXX across European markets, with both companies pursuing integrated diagnostics plus imaging service models that provide a recurring service revenue advantage over standalone imaging equipment vendors.
05
Which geographic markets show the fastest growth?
Asia Pacific registers the fastest CAGR driven by rapidly expanding companion animal ownership and veterinary clinic infrastructure investment in China, Japan, and Australia. Europe registers steady growth shaped by the ACVR-ECVDI standardisation framework and Mars SYNLAB Vet acquisition. North America leads by absolute revenue anchored by IDEXX’s cloud imaging infrastructure and academic veterinary hospital investment.
06
What are the key innovation directions shaping the 2026 to 2035 outlook?
Cloud-based imaging informatics and teleradiology platform expansion (IDEXX), compact mobile low-dose advanced imaging devices (Adaptix Ortho350 precedent), cross-Atlantic professional reporting standard compliance with the ACVR-ECVDI December 2024 framework, continued direct radiography displacement of legacy computed radiography systems, and AI-assisted pre-read triage tool integration within board-certified radiologist teleradiology workflows.
07
What verified strategic events have most shaped competition to Q2 2026?
Mars-SYNLAB Vet acquisition (September 2024), ACVR-ECVDI imaging report consensus statement (December 2024), Adaptix Ortho350 MHRA registration (March 2025), Esaote MyLab AI ultrasound FDA clearance (June 2025), UC Davis imaging hub opening (September 2025), Adaptix Ortho350 FDA 510(k) clearance (November 2025), and IDEXX next-generation DR system with AI triage FDA clearance (February 2026).
08
What is the key competitive structure and which company holds the leading position?
IDEXX Laboratories holds the leading position through its cloud-based diagnostic imaging software and services platform with confirmed double-digit recurring revenue growth throughout 2024. Mars, Incorporated holds the second position through its combined Antech, SOUND, and newly acquired SYNLAB Vet imaging infrastructure. The market is bifurcating between large integrated diagnostics-plus-imaging consolidators at the top and specialist modality equipment vendors at the specialty referral hospital equipment layer.
Table of Contents
Report structure · 240+ pages · 110+ tables · 65+ figures
Chapter 01 Executive Summary
  • Market snapshot: USD 1.42B (2025), USD 3.32B (2035), 8.9% CAGRp. 4
  • Eight key findings and investment themesp. 8
  • Analyst perspectives: Markus Kellner and Shreya Venkatp. 10
  • Regional and segment revenue breakdownp. 14
Chapter 02 Market Synopsis & Methodology
  • Scope: modality, technology, application, end-use, regionp. 18
  • Bottom-up market sizing and primary source frameworkp. 22
  • AI interpretation accuracy validation frameworkp. 26
  • ACVR-ECVDI professional standard overviewp. 30
Chapter 03 Market Dynamics
  • Driver 1: IDEXX cloud imaging software recurring revenuep. 34
  • Driver 2: Adaptix Ortho350 FDA clearance orthopedic imagingp. 40
  • Driver 3: Mars-SYNLAB Vet European consolidationp. 44
  • Restraint: AI accuracy gaps and capital cost barriersp. 48
Chapter 04 Segment & Regional Analysis
  • By Modality: DR, ultrasound, CT, MRIp. 54
  • By Technology: DR, CR, AI-assisted interpretationp. 68
  • By Application: orthopedics, abdominal, cardiology, oncologyp. 80
  • By End-use: GP clinics, specialty, academicp. 92
Report Scope
Digital Radiography Adaptix Ortho350 Veterinary CT/MRI AI Interpretation Cloud Imaging Software ACVR-ECVDI Standard SYNLAB Vet Imaging Teleradiology
Top Products & Platforms
  • IDEXX Cloud Imaging Software 11% growth Q3 2024, cloud-connected DR/PACS with AI triage, FDA cleared February 2026
  • Adaptix Ortho350 Compact mobile low-dose 3D imaging, FDA 510(k) cleared November 2025
  • Mars/SYNLAB Vet Imaging Network European advanced imaging network, acquired September 2024
  • UC Davis Diagnostic Imaging Hub Academic teaching hospital advanced imaging centre, opened September 2025
  • Esaote MyLab Veterinary Ultrasound AI-assisted cardiac and abdominal measurement tools, FDA cleared June 2025
Key Regulatory Milestones
  • Mars / SYNLAB VetSep 2024
  • ACVR / ECVDIDec 2024
  • MHRA / AdaptixMar 2025
  • FDA / EsaoteJun 2025
  • Academic / UC DavisSep 2025